PL3589638T3 - Związki użyteczne do hamowania ror-gamma-t - Google Patents

Związki użyteczne do hamowania ror-gamma-t

Info

Publication number
PL3589638T3
PL3589638T3 PL18710653T PL18710653T PL3589638T3 PL 3589638 T3 PL3589638 T3 PL 3589638T3 PL 18710653 T PL18710653 T PL 18710653T PL 18710653 T PL18710653 T PL 18710653T PL 3589638 T3 PL3589638 T3 PL 3589638T3
Authority
PL
Poland
Prior art keywords
gamma
compounds useful
inhibiting ror
ror
inhibiting
Prior art date
Application number
PL18710653T
Other languages
English (en)
Inventor
Christian Alexander Clarke
Charles Willis Lugar Iii
John Richard Morphy
Timothy Ivo Richardson
Helene Rudyk
Selma Sapmaz
Ryan Edward Stites
Grant Mathews Vaught
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of PL3589638T3 publication Critical patent/PL3589638T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18710653T 2017-03-02 2018-02-27 Związki użyteczne do hamowania ror-gamma-t PL3589638T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762466117P 2017-03-02 2017-03-02
PCT/US2018/019920 WO2018160550A1 (en) 2017-03-02 2018-02-27 Compounds useful for inhibiting ror-gamma-t
EP18710653.9A EP3589638B1 (en) 2017-03-02 2018-02-27 Compounds useful for inhibiting ror-gamma-t

Publications (1)

Publication Number Publication Date
PL3589638T3 true PL3589638T3 (pl) 2021-09-27

Family

ID=61622740

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18710653T PL3589638T3 (pl) 2017-03-02 2018-02-27 Związki użyteczne do hamowania ror-gamma-t

Country Status (15)

Country Link
US (1) US11008336B2 (pl)
EP (1) EP3589638B1 (pl)
JP (1) JP6766273B2 (pl)
CN (1) CN110337440B (pl)
CY (1) CY1124177T1 (pl)
DK (1) DK3589638T3 (pl)
ES (1) ES2871911T3 (pl)
HR (1) HRP20210898T1 (pl)
HU (1) HUE054483T2 (pl)
LT (1) LT3589638T (pl)
PL (1) PL3589638T3 (pl)
PT (1) PT3589638T (pl)
RS (1) RS61788B1 (pl)
SI (1) SI3589638T1 (pl)
WO (1) WO2018160550A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022122740A1 (en) 2020-12-07 2022-06-16 Diaccurate Ror-gamma inhibitors for the treatment of ror-gamma-dependent cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05000729A (es) * 2002-07-17 2005-04-08 Warner Lambert Co Combinacion de un inhibidor alosterico de metaloproteinasa-13 de matriz con celecoxib o valdecoxib.
UA107943C2 (xx) 2009-11-16 2015-03-10 Lilly Co Eli Сполуки спіропіперидину як антагоністи рецептора orl-1
DK2501704T3 (da) 2009-11-16 2013-10-14 Lilly Co Eli Spiropiperidinforbindelser som oral-1-receptorantagonister
TWI582096B (zh) 2011-12-06 2017-05-11 美國禮來大藥廠 用於酒精依賴及濫用處理之4',5'-二氫螺[哌啶-4,7'-噻吩并[2,3-c]哌喃]化合物
WO2014179564A1 (en) 2013-05-01 2014-11-06 Vitae Pharmaceuticals, Inc. Thiazalopyrrolidine inhibitors of ror-gamma
EP3027616B1 (en) * 2013-07-30 2018-01-10 Boehringer Ingelheim International GmbH Azaindole compounds as modulators of rorc
WO2015101928A1 (en) * 2013-12-31 2015-07-09 Aurigene Discovery Technologies Limited Fused thiophene and thiazole derivatives as ror gamma modulators
EP3097095A1 (en) * 2014-01-24 2016-11-30 AbbVie Inc. Furo-3-carboxamide derivatives and methods of use
JO3638B1 (ar) * 2015-09-09 2020-08-27 Lilly Co Eli مركبات مفيدة في تثبيط ror - جاما- t
US10603320B2 (en) * 2017-03-02 2020-03-31 Eli Lilly And Company Compounds useful for inhibiting ROR-gamma-t

Also Published As

Publication number Publication date
JP2020509049A (ja) 2020-03-26
WO2018160550A1 (en) 2018-09-07
CY1124177T1 (el) 2022-05-27
DK3589638T3 (da) 2021-06-07
EP3589638B1 (en) 2021-04-07
PT3589638T (pt) 2021-05-27
US11008336B2 (en) 2021-05-18
US20200048279A1 (en) 2020-02-13
CN110337440B (zh) 2021-08-03
EP3589638A1 (en) 2020-01-08
JP6766273B2 (ja) 2020-10-07
CN110337440A (zh) 2019-10-15
ES2871911T3 (es) 2021-11-02
HUE054483T2 (hu) 2021-09-28
LT3589638T (lt) 2021-06-10
HRP20210898T1 (hr) 2021-08-20
SI3589638T1 (sl) 2021-08-31
RS61788B1 (sr) 2021-06-30

Similar Documents

Publication Publication Date Title
IL274540B (en) Compounds useful for cdk7 inhibition
GB201708456D0 (en) Senolytic compounds
GB201700814D0 (en) Compounds
GB201704327D0 (en) Compounds
GB201704325D0 (en) Compounds
IL257202B (en) Compounds useful for ror–gamma–t inhibition
IL272815B (en) Morpholinylpyridone compounds
GB201707938D0 (en) Compounds
GB201707856D0 (en) Compounds
GB201706162D0 (en) Compounds
GB201702221D0 (en) Compounds
PT3589637T (pt) Compostos úteis para inibir ror-gamma-t
HUE054483T2 (hu) ROR-gamma-T gátlására alkalmas vegyületek
GB201707852D0 (en) Compounds
GB201703282D0 (en) Compounds
GB201713318D0 (en) Compounds
GB201711982D0 (en) Compounds
GB201709642D0 (en) Compounds
GB201708845D0 (en) Compounds
GB201708848D0 (en) Compounds
GB201708846D0 (en) Compounds
GB201707966D0 (en) Compounds
GB201707917D0 (en) Compounds
GB201706304D0 (en) Compounds
GB201706309D0 (en) Compounds